Dealing in Securities by Directors ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number 1985/0002935/06 Share code: APN ISIN: ZAE000066692 ("Aspen" or "the Company") DEALING IN SECURITIES BY DIRECTORS In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is made of the following information: Deferred bonus shares, awarded in 2015 in respect of the Aspen South African Management Deferred Incentive Scheme, have vested and have been accepted by the undermentioned directors of the Company. BY DIRECTORS OF THE COMPANY: Director : Michael Guy Attridge Company : Aspen Pharmacare Holdings Limited Date of transaction : 6 November 2018 Shares delivered – off market : 7 798 Price : R 163.01 Value of shares delivered : R 1 271 151.98 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Yes BY DIRECTORS OF THE COMPANY: Director : Stephen Bradley Saad Company : Aspen Pharmacare Holdings Limited Date of transaction : 6 November 2018 Shares delivered – off market : 9 576 Price : R 163.01 Value of shares delivered : R 1 560 893.76 Class of securities : Ordinary shares Nature of interest : Direct beneficial Clearance obtained : Yes Durban 7 November 2018 Sponsor Investec Bank Limited Date: 07/11/2018 05:45:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.